CFTR2 Presentation to FDA

First Page		Document Content
Cystic fibrosis transmembrane conductance regulator Cystic fibrosis Genotype Null allele Congenital absence of the vas deferens Polymorphism Mutation CFTR Ion channel Biology Genetics Health		CFTR2 Presentation to FDA Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 1,18 MB Share Document on Facebook

	OPEN SUBJECT AREAS: FLUORESCENCE IMAGING DRUG DEVELOPMENT HIGH-THROUGHPUT SCREENING DocID: 1pyUW - View Document
	Rev Physiol Biochem PharmacolDOI112_2006_0605 G. Zifarelli · M. Pusch CLC chloride channels and transporters: DocID: 1oypZ - View Document
	Leaflet 3 Newborn Bloodspot Screening Programme: Child is a Healthy Carrier of Cystic Fibrosis For parents who have been informed following screening that their child does not have cystic fibrosis, but is a healthy carr DocID: 1fIWB - View Document
	Blease Design Limited 0.2 years DEVELOPMENT OF AN AORTIC DocID: 1abMQ - View Document
	For New and Renewal Applications (PHS 398) – DO NOT SUBMIT UNLESS REQUESTED PHS 398 OTHER SUPPORT Provide active and pending support for all senior/key personnel. Other Support includes all financial resources, whether DocID: 19Pzz - View Document